Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 05, 2021

SELL
$54.64 - $61.3 $764 - $858
-14 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$59.18 - $69.99 $828 - $979
14 New
14 $1,000
Q4 2020

Feb 09, 2021

SELL
$50.47 - $66.26 $2,018 - $2,650
-40 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$51.97 - $63.0 $2,078 - $2,520
40 New
40 $2,000
Q2 2020

Aug 10, 2020

SELL
$30.8 - $52.47 $5,236 - $8,919
-170 Closed
0 $0
Q4 2018

Feb 15, 2019

SELL
$41.31 - $52.16 $4,131 - $5,216
-100 Reduced 37.04%
170 $7,000
Q1 2018

Apr 23, 2018

BUY
$29.98 - $46.35 $2,998 - $4,635
100 Added 58.82%
270 $0
Q2 2017

Aug 17, 2017

BUY
N/A
170
170 $8,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $769M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Advisory Services Network, LLC Portfolio

Follow Advisory Services Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisory Services Network, LLC with notifications on news.